A Framework for Assessing the Opportunity for Advanced Research, Development, and Regulatory Approval of Medical Countermeasures: A Component of BARDA's Emerging Infectious Diseases Strategy - Top-Institutions - MDSpire

A Framework for Assessing the Opportunity for Advanced Research, Development, and Regulatory Approval of Medical Countermeasures: A Component of BARDA's Emerging Infectious Diseases Strategy

  • By

  • Richard C White

  • Rachael G Lewis

  • James D Little

  • Brenda L Fredericksen

  • Carol L Sabourin

  • M Chelsea Lane

  • Shannon G Loelius

  • Kimberly A Hofmeyer

  • Matthew Steele

  • Xiaomi Tong

  • Robert A Johnson

  • October 9, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Vaccine Development
    • Immunology
    • Regulatory Science

  • #2

    Biomedical Advanced Research and Development Authority (BARDA)
    Biomedical Advanced Research and Development Authority (BARDA)

    Washington, DC

    Key Differentiators

    • Medical Countermeasure Development
    • Regulatory Science
    • Pandemic Preparedness

  • #3

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Epidemiology
    • Emerging Infectious Diseases
    • Vaccine Research

  • #4

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Disease Surveillance
    • Vaccine Development Support
    • Public Health Preparedness

  • #5

    Vaccine Research Center (VRC), NIAID
    Vaccine Research Center (VRC), NIAID

    Bethesda, MD

    Key Differentiators

    • Vaccine Design
    • Immunology
    • Clinical Trials

Original Source(s)

A Framework for Assessing the Opportunity for Advanced Research, Development, and Regulatory Approval of Medical Countermeasures: A Component of BARDA's Emerging Infectious Diseases Strategy

  • by Richard C White, Rachael G Lewis, James D Little, Brenda L Fredericksen, Carol L Sabourin, M Chelsea Lane, Shannon G Loelius, Kimberly A Hofmeyer, Matthew Steele, Xiaomi Tong, Robert A Johnson

  • October 9, 2025

Related Content

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

GLP-1 Drugs Linked to GI Effects, Uncertain Signals

Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects.